240 related articles for article (PubMed ID: 15471249)
1. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
Mitchell H; Hocking J; Saville M
Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
[TBL] [Abstract][Full Text] [Related]
2. ThinPrep Pap Test. Accuracy for glandular disease.
Ashfaq R; Gibbons D; Vela C; Saboorian MH; Iliya F
Acta Cytol; 1999; 43(1):81-5. PubMed ID: 9987455
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status.
Mitchell HS
Cancer; 2001 Aug; 93(4):237-40. PubMed ID: 11507695
[TBL] [Abstract][Full Text] [Related]
4. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases.
Lee KR; Minter LJ; Granter SR
Am J Clin Pathol; 1997 Jan; 107(1):30-5. PubMed ID: 8980364
[TBL] [Abstract][Full Text] [Related]
5. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
[TBL] [Abstract][Full Text] [Related]
6. Smear misclassification in a cervical cancer screening programme.
Lynge E; Arffmann E; Poll P; Anderson PK
Br J Cancer; 1993 Aug; 68(2):368-73. PubMed ID: 8347493
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix.
Erzen M; Mozina A; Bertole J; Syrjänen K
Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):185-91. PubMed ID: 11858896
[TBL] [Abstract][Full Text] [Related]
8. Recent negative cytology prior to histologically confirmed carcinoma in situ of the cervix.
Mitchell H; Higgins V
Aust N Z J Obstet Gynaecol; 1994 May; 34(2):178-81. PubMed ID: 7980308
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
Pettersson F; Näslund I; Malker B
IARC Sci Publ; 1986; (76):91-105. PubMed ID: 3570419
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
11. Atypical glandular cells in conventional cervical smears: incidence and follow-up.
Scheiden R; Wagener C; Knolle U; Dippel W; Capesius C
BMC Cancer; 2004 Jul; 4():37. PubMed ID: 15257755
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of women with negative cervical smears according to endocervical status.
Mitchell H; Medley G
Lancet; 1991 Feb; 337(8736):265-7. PubMed ID: 1671112
[TBL] [Abstract][Full Text] [Related]
13. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.
Mitchell H; Medley G; Gordon I; Giles G
Br J Cancer; 1995 Apr; 71(4):894-7. PubMed ID: 7710961
[TBL] [Abstract][Full Text] [Related]
14. Cytologic features of squamous cell carcinoma in situ involving endocervical glands in endocervical cytobrush specimens.
Selvaggi SM
Acta Cytol; 1994; 38(5):687-92. PubMed ID: 8091898
[TBL] [Abstract][Full Text] [Related]
15. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
Lynge E; Poll P
IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ.
Roberts JM; Thurloe JK; Bowditch RC; Humcevic J; Laverty CR
Acta Cytol; 1999; 43(1):74-80. PubMed ID: 9987454
[TBL] [Abstract][Full Text] [Related]
17. The fallacy of the screening interval for cervical smears.
Boyce JG; Fruchter RG; Romanzi L; Sillman FH; Maiman M
Obstet Gynecol; 1990 Oct; 76(4):627-32. PubMed ID: 2216192
[TBL] [Abstract][Full Text] [Related]
18. Increase Pap smear uptake.
Zardawi I
Med J Aust; 1998 Mar; 168(5):252. PubMed ID: 9539906
[No Abstract] [Full Text] [Related]
19. Does screening by "Pap" smears help prevent cervical cancer? A case-control study.
Clarke EA; Anderson TW
Lancet; 1979 Jul; 2(8132):1-4. PubMed ID: 87887
[TBL] [Abstract][Full Text] [Related]
20. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases.
Krane JF; Granter SR; Trask CE; Hogan CL; Lee KR
Cancer; 2001 Feb; 93(1):8-15. PubMed ID: 11241260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
